S
Sawsan A. Zaitone
Researcher at Suez Canal University
Publications - 109
Citations - 1843
Sawsan A. Zaitone is an academic researcher from Suez Canal University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 21, co-authored 84 publications receiving 1208 citations. Previous affiliations of Sawsan A. Zaitone include University of Tabuk.
Papers
More filters
Journal ArticleDOI
Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.
TL;DR: This study reinforces the view that acetyl-L-carnitine and α-lipoic acid are promising candidates for neuroprotection in Parkinson's disease.
Journal ArticleDOI
Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF.
TL;DR: Evidence is provided that the effect of rosuvastatin on myocardial-infarct rats involves induction of angiogenesis, as well as the cardioprotective effect of statins after different types of ischemic injury.
Journal ArticleDOI
Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats.
TL;DR: VIN and PIR exhibit neuroprotective activity in rotenone-induced Parkinsonism and may be considered as possible candidates in the treatment of Parkinson's disease.
Journal ArticleDOI
Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson’s disease therapy
Sawsan A. Zaitone,Sawsan A. Zaitone,Eman M. Ahmed,Nehal M. Elsherbiny,Nehal M. Elsherbiny,Eman T. Mehanna,Mohammed K. El-Kherbetawy,Mohamed H. ElSayed,Duha M. Alshareef,Yasser M. Moustafa +9 more
TL;DR: The results confirmed the anti-inflammatory activity of caffeic acid and highlighted its neuroprotective activity against rotenone-induced neurodegeneration in mice.
Journal ArticleDOI
Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation.
TL;DR: Overall, the current results showed that metformin protected against DMH-induced colon cancer in non-diabetic and diabetic mice, attributed to its anti-angiogenic and anti-proliferative mechanisms.